EstechPharma Co Ltd
KOSDAQ:041910
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| KR |
E
|
EstechPharma Co Ltd
KOSDAQ:041910
|
91.4B KRW |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
993.5B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
590.8B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
292.8B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.2B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
244.9B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
307.1B USD |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
153.9B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
123.1B USD |
Loading...
|
Market Distribution
| Min | -646.5% |
| 30th Percentile | 12.8% |
| Median | 19.7% |
| 70th Percentile | 32.2% |
| Max | 54 001.3% |
Other Profitability Ratios
EstechPharma Co Ltd
Glance View
Estechpharma Co., Ltd. engages in the manufacture and supply of pharmaceutical ingredients and fine chemicals. The company is headquartered in Hwaseong, Gyeonggi-Do and currently employs 162 full-time employees. The company went IPO on 2004-02-06. The Company’s products include remedies for alcoholism, anti-inflammatory, muscle relaxant, anti-septic, anti-spasmodic, anti-cataract, capillary protectant, unnatural amino acid, anti-hepatitis, anti-parkinsonian, anti-histamine, anti-ulcerants, anti-rheumatics, anti-anemia, anti-diabetic, insecticide, anti-hypertensive, anti-asthmatic and anti-depressants, among others. The company has a research and development institute, which develops APIs. The firm distributes its products within domestic market and to overseas markets.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for EstechPharma Co Ltd is 20.7%, which is below its 3-year median of 21.1%.
Over the last 3 years, EstechPharma Co Ltd’s Gross Margin has increased from 20.2% to 20.7%. During this period, it reached a low of 18.9% on Dec 31, 2024 and a high of 22.4% on Jun 30, 2023.
